Everence Capital Management’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,960
Closed -$294K 1038
2024
Q3
$294K Hold
6,960
0.02% 599
2024
Q2
$319 Hold
6,960
0.02% 525
2024
Q1
$362 Hold
6,960
0.02% 515
2023
Q4
$248K Hold
6,960
0.02% 625
2023
Q3
$233 Sell
6,960
-1,860
-21% -$64.5K 0.02% 614
2023
Q2
$283K Hold
8,820
0.02% 544
2023
Q1
$259 Hold
8,820
0.02% 592
2022
Q4
$232 Hold
8,820
0.02% 633
2022
Q3
$205K Hold
8,820
0.02% 650
2022
Q2
$222K Hold
8,820
0.02% 605
2022
Q1
$337K Hold
8,820
0.03% 525
2021
Q4
$347K Hold
8,820
0.03% 545
2021
Q3
$430K Buy
8,820
+2,340
+36% +$121K 0.04% 444
2021
Q2
$340K Hold
6,480
0.03% 530
2021
Q1
$360K Buy
+6,480
New +$293K 0.03% 481

Other funds holding VCEL

Everence Capital Management's VCEL Position: Q4 2024 in Review

Everence Capital Management sold out of Vericel Corp (VCEL) in Q4 2024, closing a stake of 6,960 shares — an estimated $294K sold.

Everence Capital Management first reported a position in VCEL in Q1 2021 and held it in 15 quarters. The position peaked at $430K in Q3 2021. 278 funds tracked by Wall St. Rank hold VCEL as of Q4 2024.

  • Everence Capital Management reported no remaining Vericel Corp position as of Q4 2024 after selling out during the quarter.
  • Everence Capital Management sold 6,960 Vericel Corp shares in Q4 2024, an estimated $294K.
  • Everence Capital Management first reported a position in Vericel Corp in Q1 2021 and held it in 15 quarters.
  • Everence Capital Management's Vericel Corp position peaked at $430K in Q3 2021.
  • 278 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2024.

Based on Everence Capital Management's 13F filing for Q4 2024, filed 3 Jan 2025.